As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are ...

While industry groups decried the Trump administration’s new drug pricing order, analysts say it lacked details and the teeth ...

To more effectively treat neurodegenerative conditions, we first need diagnostic tools that lend a more complete picture of ...

Roche committed $50 billion in U.S. manufacturing funds, with which it will construct at least four new facilities.

In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...

The FDA and CDC have also recommended pausing the use of Ixchiq in seniors 60 years and older while safety investigations are ...

While Quantum computing has been reported to be five years away for many years now, companies are preparing for it by setting ...

The Plavix lawsuit dates back to 2014, when Hawaii first sued BMS and Sanofi, alleging that they failed to properly inform ...

At the intersection of radiation and precision, Novartis, Bayer, AstraZeneca and more hope to cash in on a ...

The cell engineering company, co-founded by oncologist and writer Siddhartha Mukherjee, does not see a path forward for its ...

After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review ...

The missed PDUFA adds to a string of delays at the FDA in recent weeks, including at least two other missed target action ...